Herman Morris - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 25px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Mr. Herman Morris Jr. is an Independent Director of the Company. Since October 2009, he was City Attorney of the City of Memphis. From 2006 to October 2009, he was in the private practice of law in Memphis, Tennessee. In 2006, Mr. Morris served as Vice President and General Counsel of Pinnacle Airlines. Mr. Morris was a partner in the Baker, Donaldson, Bearman, Caldwell and Berkowitz law firm in Memphis, Tennessee from 2004 to 2006. He served as President and Chief Executive Officer of Memphis Light, Gas and Water Division from 1997 until 2004. Prior to that, Mr. Morris was General Counsel of Memphis Light, Gas and Water Division. Mr. Morris also serves on several private company and nonprofit boards.
Age: 63  Director Since 1999      
353 1 709 4000  http://www.perrigo.com

Herman Morris Latest Insider Activity

Herman Morris over three months ago via Macroaxis 
Perrigo Company exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Anupam PuriDr Reddys Laboratories Ltd
2002
Joseph GoldsteinRegeneron Pharmaceuticals
1991
Yingqi XiaOrigin Agritech Limited
2010
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Kalpana MorpariaDr Reddys Laboratories Ltd
2007
Fei WangOrigin Agritech Limited
2019
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Huda ZoghbiRegeneron Pharmaceuticals
2016
Willie ReedZoetis
2014
Prasad MenonDr Reddys Laboratories Ltd
2019
Lloyd CarneyVertex Pharmaceuticals Incorpor
2019
Arthur RyanRegeneron Pharmaceuticals
2003
Linda RhodesZoetis
2017
Christine PoonRegeneron Pharmaceuticals
2010
William DoyleZoetis
2015
Paul BisaroZoetis
2015
George SingRegeneron Pharmaceuticals
1988
Louise ParentZoetis
2013
Leo PuriDr Reddys Laboratories Ltd
2018
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
few hours ago
Traded for 55.68
IJR   
Purchased few shares of
few hours ago
Traded for 85.37
IJH   
Purchased one share of
few hours ago
Traded for 209.15
IVV   
Purchased one share of
few hours ago
Traded for 333.5
IDEV   
Purchased few shares of
few hours ago
Traded for 59.01
Please also check Your Equity Center. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.